Literature DB >> 33618713

FZD5 prevents epithelial-mesenchymal transition in gastric cancer.

Dan Dong1, Lei Na1,2, Kailing Zhou1, Zhuo Wang1, Yu Sun1, Qianqian Zheng1, Jian Gao3, Chenghai Zhao4, Wei Wang5.   

Abstract

BACKGROUND: Frizzled (FZD) proteins function as receptors for WNT ligands. Members in FZD family including FZD2, FZD4, FZD7, FZD8 and FZD10 have been demonstrated to mediate cancer cell epithelial-mesenchymal transition (EMT).
METHODS: CCLE and TCGA databases were interrogated to reveal the association of FZD5 with EMT. EMT was analyzed by investigating the alterations in CDH1 (E-cadherin), VIM (Vimentin) and ZEB1 expression, cell migration and cell morphology. Transcriptional modulation was determined by ChIP in combination with Real-time PCR. Survival was analyzed by Kaplan-Meier method.
RESULTS: In contrast to other FZDs, FZD5 was identified to prevent EMT in gastric cancer. FZD5 maintains epithelial-like phenotype and is negatively modulated by transcription factors SNAI2 and TEAD1. Epithelial-specific factor ELF3 is a downstream effecter, and protein kinase C (PKC) links FZD5 to ELF3. ELF3 represses ZEB1 expression, further guarding against EMT. Moreover, FZD5 signaling requires its co-receptor LRP5 and WNT7B is a putative ligand for FZD5. FZD5 and ELF3 are associated with longer survival, whereas SNAI2 and TEAD1 are associated with shorter survival.
CONCLUSIONS: Taken together, FZD5-ELF3 signaling blocks EMT, and plays a potential tumor-suppressing role in gastric cancer. Video Abstract.

Entities:  

Keywords:  ELF3; Epithelial-mesenchymal transition; FZD5; Gastric cancer

Mesh:

Substances:

Year:  2021        PMID: 33618713      PMCID: PMC7898745          DOI: 10.1186/s12964-021-00708-z

Source DB:  PubMed          Journal:  Cell Commun Signal        ISSN: 1478-811X            Impact factor:   5.712


  50 in total

1.  The ETS transcription factor ESE-1 transforms MCF-12A human mammary epithelial cells via a novel cytoplasmic mechanism.

Authors:  Jason D Prescott; Karen S N Koto; Meenakshi Singh; Arthur Gutierrez-Hartmann
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

2.  Alternative Wnt Signaling Activates YAP/TAZ.

Authors:  Hyun Woo Park; Young Chul Kim; Bo Yu; Toshiro Moroishi; Jung-Soon Mo; Steven W Plouffe; Zhipeng Meng; Kimberly C Lin; Fa-Xing Yu; Caroline M Alexander; Cun-Yu Wang; Kun-Liang Guan
Journal:  Cell       Date:  2015-08-13       Impact factor: 41.582

3.  FZD8 Indicates a Poor Prognosis and Promotes Gastric Cancer Invasion and Metastasis via B-Catenin Signaling Pathway.

Authors:  Wen Chen; Zhiwen Liu; Wenli Mai; Yu Xiao; Xiaolong You; Lei Qin
Journal:  Ann Clin Lab Sci       Date:  2020-01       Impact factor: 1.256

4.  WNT5A: a motility-promoting factor in Hodgkin lymphoma.

Authors:  F Linke; S Zaunig; M M Nietert; F von Bonin; S Lutz; C Dullin; P Janovská; T Beissbarth; F Alves; W Klapper; V Bryja; T Pukrop; L Trümper; J Wilting; D Kube
Journal:  Oncogene       Date:  2016-06-06       Impact factor: 9.867

5.  LRP5/6 directly bind to Frizzled and prevent Frizzled-regulated tumour metastasis.

Authors:  Dan-Ni Ren; Jinxiao Chen; Zhi Li; Hongwei Yan; Yan Yin; Da Wo; Jiankang Zhang; Luoquan Ao; Bo Chen; Takashi K Ito; Yihan Chen; Zhongmin Liu; Yongyong Li; Jianhua Yang; Xiaoling Lu; Yi Peng; Linghui Pan; Yongxiang Zhao; Shangfeng Liu; Weidong Zhu
Journal:  Nat Commun       Date:  2015-04-22       Impact factor: 14.919

6.  H3K27me3-mediated PGC1α gene silencing promotes melanoma invasion through WNT5A and YAP.

Authors:  Chi Luo; Eduardo Balsa; Elizabeth A Perry; Jiaxin Liang; Clint D Tavares; Francisca Vazquez; Hans R Widlund; Pere Puigserver
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

7.  Genome-wide CRISPR screens reveal a Wnt-FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors.

Authors:  Zachary Steinhart; Zvezdan Pavlovic; Megha Chandrashekhar; Traver Hart; Xiaowei Wang; Xiaoyu Zhang; Mélanie Robitaille; Kevin R Brown; Sridevi Jaksani; René Overmeer; Sylvia F Boj; Jarrett Adams; James Pan; Hans Clevers; Sachdev Sidhu; Jason Moffat; Stéphane Angers
Journal:  Nat Med       Date:  2016-11-21       Impact factor: 53.440

8.  Protein Kinase Cι Drives a NOTCH3-dependent Stem-like Phenotype in Mutant KRAS Lung Adenocarcinoma.

Authors:  Syed A Ali; Verline Justilien; Lee Jamieson; Nicole R Murray; Alan P Fields
Journal:  Cancer Cell       Date:  2016-03-14       Impact factor: 31.743

9.  Functional consequences of WNT3/Frizzled7-mediated signaling in non-transformed hepatic cells.

Authors:  S B Nambotin; Y Tomimaru; P Merle; J R Wands; M Kim
Journal:  Oncogenesis       Date:  2012-10-22       Impact factor: 7.485

10.  ELF3 is an antagonist of oncogenic-signalling-induced expression of EMT-TF ZEB1.

Authors:  D Liu; Y Skomorovska; J Song; E Bowler; R Harris; M Ravasz; S Bai; M Ayati; K Tamai; M Koyuturk; X Yuan; Z Wang; Y Wang; R M Ewing
Journal:  Cancer Biol Ther       Date:  2018-08-27       Impact factor: 4.742

View more
  3 in total

1.  TTN-AS1 delivered by gastric cancer cell-derived exosome induces gastric cancer progression through in vivo and in vitro studies.

Authors:  Yu Wang; Rongke Jiang; Hongying Zhao; Feng Li; Yanfang Li; Mei Zhu
Journal:  Cell Biol Toxicol       Date:  2022-10-10       Impact factor: 6.819

Review 2.  Cancer chemoprevention through Frizzled receptors and EMT.

Authors:  K Sompel; A Elango; A J Smith; M A Tennis
Journal:  Discov Oncol       Date:  2021-09-09

Review 3.  Wnt/β-catenin signaling in cancers and targeted therapies.

Authors:  Fanyuan Yu; Changhao Yu; Feifei Li; Yanqin Zuo; Yitian Wang; Lin Yao; Chenzhou Wu; Chenglin Wang; Ling Ye
Journal:  Signal Transduct Target Ther       Date:  2021-08-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.